October 3, 2016 / 12:02 PM / a year ago

BRIEF-Castle Creek Pharmaceuticals announces results at EADV of phase 2 topical diacerein 1% data

Oct 3 (Reuters) - Castle Creek Pharmaceuticals

* Castle Creek Pharmaceuticals announces late-breaking results at EADV of phase 2 topical diacerein 1% data in patients with epidermolysis bullosa simplex (ebs) Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below